Nanosphere Inc (NSPH): International Inc. Spc Mmcap , 10% owner of Nanosphere Inc purchased 176,781 shares on May 24, 2016. The Insider buying transaction was reported by the company on May 26, 2016 to the Securities and Exchange Commission. The shares were purchased at $1.68 per share for a total value of $297,165.12 , the company said in a SEC Form 4 Filing.
Nanosphere: On Wednesday, May 25, 2016 heightened volatility was witnessed in Nanosphere which led to swings in the share price. The shares opened for trading at $1.69 and hit $1.7 on the upside , eventually ending the session at $1.7, with a gain of 0.59% or 0.01 points. The heightened volatility saw the trading volume jump to 22,39,470 shares. The 52-week high of the share price is $3.9025 and the company has a market cap of $23 M . The 52-week low of the share price is at $0.4801.
Company has been under the radar of several Street Analysts.Nanosphere is Downgraded by Rodman & Renshaw to Neutral while Lowering the Price Target of the company shares to $ 1.35 from a previous price target of $2 . Earlier the firm had a rating of Buy on the company shares. The Rating was issued on May 17, 2016.Nanosphere is Initiated by Rodman & Renshaw to Buy and the brokerage firm has set the Price Target at $2. The Rating was issued on Mar 8, 2016.
Nanosphere Inc. is engaged in developing manufacturing and marketing an advanced molecular diagnostics platform the Verigene System which enables genomic and protein testing on a single platform. The Company’s nanoparticle technology provides the solution to run multiple tests simultaneously on the same sample. The Verigene System includes a bench-top molecular diagnostics workstation that is a universal platform for genomic and protein testing. The Verigene System provides for multiple tests to be performed on a single platform including both genomic and protein assays from a single sample. The Verigene System is comprised of a microfluidics processor a touchscreen reader certain disposable consumables used in sample preparation target amplification and test cartridges. The Company is focused on the infectious disease diagnostics market.